Skip to content

Goran Broketa, MD

NPI 1033153374ActiveIndividual· Internal Medicine, Hematology & Oncology· Manchester, NH

Internal Medicine, Hematology & Oncology (MD) in Manchester, New Hampshire, licensed in PA, with an NPI issued in June 2006. Part D covered 23 prescriptions written in 2024, 100% of them generic. Astellas Pharma US Inc reported $99.95 in payments in 2025, mostly education.

Overview

NPI1033153374
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedJun 16, 2006
Last updated in NPPESNov 12, 2010

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine, Hematology & Oncology Primary207RH0003XMD060211LPA

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Order and Referring Only - Hematology/Oncology (NH)

Part D prescriptions in 2024

Prescriptions (claims)23 · 36 30-day fills
Total drug cost$139.74
Generic share100% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$99.95 · 1 payment from 1 company
  • 2024$99.99 · 1 payment from 1 company

Top paying companies in 2025

CompanyAmountPayments
Astellas Pharma US Inc$99.951

What the 2025 payments were for

  • Education$99.95 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other hematologist-oncologists in Manchester

All hematologist-oncologists in New Hampshire